Hepatitis B Therapies Chart

liver411

Hepatitis B Therapies Chart Compiled by Ronald Baker, PhD Drug Name Drug Class Company FDA Status Intron A (interferon alfa-2b) interferon Schering-Plough FDA-approved Epivir-HBV (lamivudine; 3TC) nucleoside analogue GlaxoSmithKline FDA-approved Adefovir dipivoxil nucleoside analogue Gilead Sciences Phase III * NDA filed March 2002 Coviracil (emtricitabine; FTC) nucleoside analogue Triangle Pharmaceuticals Phase III NDA filing expected in 2002 Entecavir nucleoside analogue Bristol-Myers Squibb Phase III Clevudine (L-FMAU) nucleoside analogue Triangle Pharmaceuticals Phase II ACH 126, 443 (L-Fd4C) nucleoside analogue Achillion Pharmaceuticals Phase II AM 365 nucleoside analogue Amrad Phase II (Asia and Australia) DAPD nucleoside analogue Triangle Pharmaceuticals Phase II LdT nucleoside analogue Novirio Phase II XTL 001 monoclonal antibody XTL Biopharm Phase II (Israel) Theradigm Immune stimulant Epimmune Phase II Zadaxin** (thymosin) Immune stimulant SciClone Phase II with Epivir-HBV EHT 899 viral protein Enzo Biochem Phase II (Israel) LdC nucleoside analogue Novirio Phase I HBV DNA vaccine Immune stimulant PowderJect (UK) Phase I MCC 478 nucleoside analogue Eli Lilly Phase I (Germany) ICN 2001 nucleoside analogue ICN Preclinical Fluro L and D nucleosides nucleoside analogue Pharmasset Preclinical Racivir nucleoside analogue Pharmasset Preclinical Robustaflavone nucleoside analogue Advanced Life Sciences Preclinical Post Exposure and/or Post Liver Transplant Therapies BayHepB HBV immuneglobulin Bayer (US) FDA-approved anti-hepatitis B HBV immuneglobulin Cangene (Canada) NDA submitted 2001 Nabi-HB HBV immuneglobulin Nabi FDA-approved *Adefovir dipivoxil: now available to patients with lamivudine-resistant HBV through an Expanded Access Program. Physicians may call 1-800-GILEAD-5 or 1-650-574-3000. **Zadaxin: orphan drug approval in US Sources: Mark Nelson, MD. Selected Highlights from Drug Development for Antiretroviral Therapies 2001 (Hep DART 2001) December 16-20, 2001, Maui, Hawaii. New Medicines in Development. Pharmaceutical Research and Manufacturers [ 此消息由 liver411 在 2002-04-11.03:09:35 编辑过 ]